Presentations covered:
- Varenicline: implications for the field
- Marketing stop smoking services to
help reach targets
- Professional standards, clinical supervision
and training
- Smoking cessation and young people
- Where next for smoking cessation?
Conference planning group
Programme directors:
Andy McEwen, Cancer Research UK Health Behaviour Unit, University College London and Hayden McRobbie, University of Auckland.
Programme committee:
Miriam Armstrong, Pharmacy Health Link, RPSGB; Deborah Arnott, Action on Smoking and Health (ASH); Steve Crone, QUIT; Linda Durgan, All Wales Smoking Cessation Service; Trish Grierson, Dumfries and Galloway Primary Care NHS Trust; Peter Hajek, Tobacco Dependence Research and Treatment Centre, Barts and the London Queen Mary's School of Medicine and Dentistry; Elspeth Lee, Behaviour Research and Tobacco Control, Cancer Research UK; Gerry McElwee, ASH Northern Ireland; Ann McNeill, University of Nottingham; Lesley Owen, National Institute for Clinical Excellence; Gay Sutherland, Maudsley Hospital Smoking Cessation Clinic; Robert West, Cancer Research UK Health Behaviour Unit, University College London; Ben Youdan, No Smoking Day.
Conference partners:
Action on Smoking and Health (ASH); ASH Scotland; ASH Wales; ASH Northern Ireland; Association for the Treatment of Tobacco Use and Dependence (ATTUD); British Medical Association; Cancer Research UK; No Smoking Day; Pharmacy Health Link; Pip Mason Consultancy; QUIT; Royal College of Nursing; Society for the Study of Addiction.
|
|
|
